Results 51 to 60 of about 513,064 (187)

Relapsing fever in a traveller returning from Senegal

open access: yes, 2021
KEY POINTS • A broad differential should be maintained in the returning traveller with fever, and a detailed travel, social and exposure history elicited to help guide appropriate diagnostics. • Spirochetes seen in routine peripheral blood or malaria
Eckbo, Eric   +7 more
core   +1 more source

Transcriptional Profiling the 150 kb Linear Megaplasmid of Borrelia turicatae Suggests a Role in Vector Colonization and Initiating Mammalian Infection. [PDF]

open access: yesPLoS ONE, 2016
Adaptation is key for survival as vector-borne pathogens transmit between the arthropod and vertebrate, and temperature change is an environmental signal inducing alterations in gene expression of tick-borne spirochetes.
Hannah K Wilder   +9 more
doaj   +1 more source

Replication enhancer elements within the open reading frame of tick-borne encephalitis virus and their evolution within the Flavivirus genus [PDF]

open access: yes, 2011
We provide experimental evidence of a replication enhancer element (REE) within the capsid gene of tick-borne encephalitis virus (TBEV, genus Flavivirus).
I. M. Jones   +22 more
core   +1 more source

Relapsing Fever Tick Ornithodoros turicata Dugès, 1876 (Acari: Ixodida: Argasidae)

open access: yesEDIS
Ornithodoros turicata (Dugès, 1876), commonly referred to as the relapsing fever tick, is a soft tick species belonging to the family Argasidae.
Moriah B. Garrison   +2 more
doaj   +1 more source

Pharmacy‐Based Immunization Delivery: A Comprehensive History and Current Challenges

open access: yesJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 6, June 2026.
ABSTRACT Pharmacists and their teams have a long history of involvement with vaccines. This paper describes the contributions of pharmacy‐based immunization delivery in the United States from the 1800's to date. Early activities centered around storage and distribution of antitoxins and vaccines. From the 1950s through the early 1990s, pharmacists were
Jean‐Venable R. Goode   +4 more
wiley   +1 more source

First cluster of relapsing fever compatible with louse-borne transmission in southern Saudi Arabia: An eight-case series from Najran

open access: yesJournal of Infection and Public Health
Louse-borne relapsing fever (LBRF), caused by Borrelia recurrentis, is a neglected vector-borne infection associated with overcrowding, migration, and poor hygiene conditions. We describe eight spatiotemporally linked cases of Borrelia spp.
Mohammed Bazuqamah   +8 more
doaj   +1 more source

Knowledge mapping of risk mitigation measures against vector‐borne diseases

open access: yesEFSA Journal, Volume 24, Issue 5, May 2026.
Abstract A comprehensive synthesis of current evidence on surveillance, prevention and control measures for 25 selected vector‐borne diseases (VBDs) affecting animals in the EU is presented here. The assessment integrates evidence from systematic literature reviews, modelling studies, field investigations and expert judgement.
European Food Safety Authority (EFSA)   +8 more
wiley   +1 more source

Tick Borne Relapsing Fever Imported into the United Kingdom [PDF]

open access: yesJournal of the Royal Army Medical Corps, 1985
A case of tick borne relapsing fever contracted in Cyprus and imported into England is reported. This is the first report of the diagnosis being established by finding the organism in the bone marrow.
openaire   +2 more sources

Tick-Borne Diseases in Turkey: A Review Based on One Health Perspective. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2016
The importance of tick-borne diseases is increasing all over the world, including Turkey. Global warming, environmental and ecological changes and the existence of suitable habitats increase the impact of ticks and result in frequent emergence or re ...
Abdullah Inci   +4 more
doaj   +1 more source

Cytokine‐Engineered Chimeric Antigen Receptor‐T Cell Therapy: How to Balance the Efficacy and Toxicity

open access: yesAdvanced Science, Volume 13, Issue 14, 9 March 2026.
Cytokine‐engineered CAR‐T cells represent a promising immunotherapy against malignancies due to direct tumor killing and potent immunity response. However, significant toxicities, including CRS and ICANS, have restricted clinical applications. How to keep the risk‐benefit balance of the advanced therapy is of great importance for maximizing the benefit
Xinru Zhang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy